371 related articles for article (PubMed ID: 16596771)
21. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.
Samson MT; Small-Howard A; Shimoda LM; Koblan-Huberson M; Stokes AJ; Turner H
J Immunol; 2003 May; 170(10):4953-62. PubMed ID: 12734338
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid Receptor 1 and 2 Signaling Pathways Involved in Sepsis.
Leite-Avalca MCG; Zampronio A; Lehmann C
Shock; 2021 Nov; 56(5):673-681. PubMed ID: 33625115
[TBL] [Abstract][Full Text] [Related]
23. Aqueous humor outflow effects of 2-arachidonylglycerol.
Njie YF; He F; Qiao Z; Song ZH
Exp Eye Res; 2008 Aug; 87(2):106-14. PubMed ID: 18597752
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.
Blume LC; Eldeeb K; Bass CE; Selley DE; Howlett AC
Cell Signal; 2015 Mar; 27(3):716-726. PubMed ID: 25446256
[TBL] [Abstract][Full Text] [Related]
25. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
26. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
Feoktistov I; Goldstein AE; Biaggioni I
Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
[TBL] [Abstract][Full Text] [Related]
27. Anandamide receptor signal transduction.
Goodfellow CE; Glass M
Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
[TBL] [Abstract][Full Text] [Related]
28. The thyrotropin receptor is not involved in the activation of p42/p44 mitogen-activated protein kinases by thyrotropin preparations in Chinese hamster ovary cells expressing the human thyrotropin receptor.
Corrèze C; Blondeau JP; Pomerance M
Thyroid; 2000 Sep; 10(9):747-52. PubMed ID: 11041451
[TBL] [Abstract][Full Text] [Related]
29. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
[TBL] [Abstract][Full Text] [Related]
30. Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells.
Lipina C; Stretton C; Hastings S; Hundal JS; Mackie K; Irving AJ; Hundal HS
Diabetes; 2010 Feb; 59(2):375-85. PubMed ID: 19933999
[TBL] [Abstract][Full Text] [Related]
31. Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium.
Kino T; Tomori T; Abutarboush R; Castri P; Chen Y; Lenz FA; McCarron RM; Spatz M
Biochem Biophys Rep; 2016 Dec; 8():254-260. PubMed ID: 28955964
[TBL] [Abstract][Full Text] [Related]
32. Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells.
Zoratti C; Kipmen-Korgun D; Osibow K; Malli R; Graier WF
Br J Pharmacol; 2003 Dec; 140(8):1351-62. PubMed ID: 14645143
[TBL] [Abstract][Full Text] [Related]
33. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
34. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.
Rossant CJ; Pinnock RD; Hughes J; Hall MD; McNulty S
Endocrinology; 1999 Apr; 140(4):1525-36. PubMed ID: 10098484
[TBL] [Abstract][Full Text] [Related]
37. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE
J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549
[TBL] [Abstract][Full Text] [Related]
38. The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling.
Nie J; Lewis DL
Neuroscience; 2001; 107(1):161-7. PubMed ID: 11744255
[TBL] [Abstract][Full Text] [Related]
39. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
Glass M; Felder CC
J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway.
Mai P; Tian L; Yang L; Wang L; Yang L; Li L
J Cell Physiol; 2015 Jul; 230(7):1640-50. PubMed ID: 25545473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
